Table 2.

ORs of ESA treatment response compared with other etiology, unadjusted and adjusted for confounders

EtiologyOR*95% CIP
Unadjusted model    
 CKD 4.20 0.962-18.3 .056 
 MDS 1.27 0.387-4.17 .693 
 AUE 3.24 0.849-12.4 .085 
Adjusted model, EPO linear†    
 CKD 3.60 0.815-15.9 .091 
 MDS 1.61 0.472-5.47 .448 
 AUE 3.30 0.838-13.0 .088 
 EPO <200 IU/L 9.28 1.14-75.4 .037 
EtiologyOR*95% CIP
Unadjusted model    
 CKD 4.20 0.962-18.3 .056 
 MDS 1.27 0.387-4.17 .693 
 AUE 3.24 0.849-12.4 .085 
Adjusted model, EPO linear†    
 CKD 3.60 0.815-15.9 .091 
 MDS 1.61 0.472-5.47 .448 
 AUE 3.30 0.838-13.0 .088 
 EPO <200 IU/L 9.28 1.14-75.4 .037 
*

OR of treatment response is relative to other etiology.

†

Includes only EPO level as a confounder. Sex, age, weight, comorbidity index, hemoglobin, eGFR, and presence of another cytopenia were not found to be statistically significant predictors of response.

[ViewLarge]
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal